You have 9 free searches left this month | for more free features.

City

Baltimore (2)

Chapel Hill (1)

Cologne (1)

Los Angeles (1)

Nashville (1)

New York (1)

Scottsdale (1)

Condition

Advanced Solid Tumor (1)

Fibrolamellar Hepatocellular Carcinoma (1)

Non Small Cell Lung Cancer Metastatic (1)

Non-Small Cell Lung Cancer Recurrent (1)

Squamous Cell Carcinoma of Head and Neck (1)

Overall Status

Not yet recruiting (1)

Recruiting (1)

Sign in for free

Phase

phase 1/phase 2 (2)

Sponsor

Dracen Pharmaceuticals, Inc. (1)

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (1)

Collaborator

Dracen Pharmaceuticals, Inc. (1)

Fibrolamellar Cancer Foundation (1)

Intervention

drp-104 (2)

atezolizumab (1)

durvalumab (1)

Study Documents

Intervention Type

drug (2)

biological (1)

Funder Type

Industry (1)

Other (1)

Study Type

Interventional (2)

drp-104

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Fibrolamellar Hepatocellular Carcinoma Trial in Baltimore (Durvalumab, DRP-104)

Not yet recruiting

Fibrolamellar Hepatocellular Carcinoma

Durvalumab
DRP-104

Baltimore, Maryland

Johns Hopkins SKCCC

Aug 30, 2023

Advanced Solid Tumor, NSCLC Recurrent, Squamous Cell Carcinoma of Head and Neck Trial in Germany, United States (DRP-104,

Recruiting

Advanced Solid Tumor
+3 more

DRP-104
atezolizumab

Scottsdale, Arizona
+8 more

Jun 20, 2021